Home / Molnupiravir / United States
US ATC J05AB18 · updated 2 Nov 2026
Molnupiravir shortage in United States
Is there a Molnupiravir shortage in United States?
Yes. As of 2 Nov 2026, 3 Molnupiravir products are reported short in United States, the first since 20 Oct 2026. No return date has been given. Main reason: not stated.
Not reported short in any other country we track. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Lagevrio, Capsule, 200 mg (NDC 0006-5055-06) discontinuation | Merck Sharp & Dohme LLC | 20 Oct 2026 | not given | Not stated |
| US | Lagevrio, Capsule, 200 mg (NDC 0006-5055-07) discontinuation | Merck Sharp & Dohme LLC | 20 Oct 2026 | not given | Not stated |
| US | Lagevrio, Capsule, 200 mg (NDC 0006-5055-09) discontinuation | Merck Sharp & Dohme LLC | 20 Oct 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).